Abstract
EB Goldbloom, A Mokashi, EA Cummings. Arch Dis Child. 2017;102(4):338–339 To determine the national incidence and presenting features of pediatric glucocorticoid-induced symptomatic adrenal suppression (AS) in Canada by using a national pediatric surveillance program. Canadian pediatricians and pediatric subspecialists in clinical practice participated in a prospective surveillance through the Canadian Pediatric Surveillance Program, surveying for rare conditions. Over 2500 pediatricians and pediatric subspecialists were surveyed monthly for 2 years through the Canadian Pediatric Surveillance Program either by mail or e-mail. A check-off form asked physicians whether they had identified any new cases of symptomatic adrenal suppression (AS). If …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
